BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 26577143)

  • 1. Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.
    Fitzpatrick JM; Biswas JS; Edgeworth JD; Islam J; Jenkins N; Judge R; Lavery AJ; Melzer M; Morris-Jones S; Nsutebu EF; Peters J; Pillay DG; Pink F; Price JR; Scarborough M; Thwaites GE; Tilley R; Walker AS; Llewelyn MJ;
    Clin Microbiol Infect; 2016 Mar; 22(3):244-51. PubMed ID: 26577143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of prior cultures in predicting antibiotic resistance of bloodstream infections due to Gram-negative pathogens: a multicentre observational cohort study.
    MacFadden DR; Coburn B; Shah N; Robicsek A; Savage R; Elligsen M; Daneman N
    Clin Microbiol Infect; 2018 May; 24(5):493-499. PubMed ID: 28811241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.
    Marschall J; Agniel D; Fraser VJ; Doherty J; Warren DK
    J Antimicrob Chemother; 2008 Jun; 61(6):1376-83. PubMed ID: 18344548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis.
    Safdar N; Handelsman J; Maki DG
    Lancet Infect Dis; 2004 Aug; 4(8):519-27. PubMed ID: 15288826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes.
    Sligl WI; Dragan T; Smith SW
    Int J Infect Dis; 2015 Aug; 37():129-34. PubMed ID: 26159847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
    Gudiol C; Tubau F; Calatayud L; Garcia-Vidal C; Cisnal M; Sánchez-Ortega I; Duarte R; Calvo M; Carratalà J
    J Antimicrob Chemother; 2011 Mar; 66(3):657-63. PubMed ID: 21193475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
    Alves MD; Ribeiro VB; Tessari JP; Mattiello F; De Bacco G; Luz DI; Vieira FJ; Behle TF; Pasqualotto AC; Zavascki AP
    J Antimicrob Chemother; 2014 Jun; 69(6):1681-7. PubMed ID: 24474430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
    Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
    J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteraemia at a second level hospital: epidemiological study, analysis of pronostic factors associated to mortality and economic cost estimation].
    Hernández-Roca JJ; García-Vázquez E; Hernández A; Canteras M; Herrero JA; Cascales E; Mené-Fenor E; Gómez-Gómez J
    Rev Esp Quimioter; 2013 Jun; 26(2):119-27. PubMed ID: 23817650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision-support models for empiric antibiotic selection in Gram-negative bloodstream infections.
    MacFadden DR; Coburn B; Shah N; Robicsek A; Savage R; Elligsen M; Daneman N
    Clin Microbiol Infect; 2019 Jan; 25(1):108.e1-108.e7. PubMed ID: 29705558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different impact of the appropriateness of empirical antibiotics for bacteremia among younger adults and the elderly in the ED.
    Lee CC; Chang CM; Hong MY; Hsu HC; Ko WC
    Am J Emerg Med; 2013 Feb; 31(2):282-90. PubMed ID: 23000336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.
    Oliveira AL; de Souza M; Carvalho-Dias VM; Ruiz MA; Silla L; Tanaka PY; Simões BP; Trabasso P; Seber A; Lotfi CJ; Zanichelli MA; Araujo VR; Godoy C; Maiolino A; Urakawa P; Cunha CA; de Souza CA; Pasquini R; Nucci M
    Bone Marrow Transplant; 2007 Jun; 39(12):775-81. PubMed ID: 17438585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection.
    Micek ST; Hampton N; Kollef M
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study.
    Khan FY; Elshafie SS; Almaslamani M; Abu-Khattab M; El Hiday AH; Errayes M; Almaslamani E
    Travel Med Infect Dis; 2010 Nov; 8(6):377-87. PubMed ID: 21074495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.